Impaired Recovery Duri ng Congested Competition in an Elite Football Player: A Longitudinal Integrative Case Report

Impaired Recovery Duri ng Congested Competition in an Elite Football Player: A Longitudinal Integrative Case Report | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Impaired Recovery Duri ng Congested Competition in an Elite Football Player: A Longitudinal Integrative Case Report Rafael Silvestre Knack, Renata Silvestre Knack, Ricardo Egídio Silvestre Knack This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-9684599/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background Interindividual variability in recovery responses represents a central challenge in elite sports, particularly during congested competition periods. Traditional biomarkers provide limited predictive value when used in isolation, highlighting the need for integrative multimodal monitoring approaches. Methods This longitudinal case report describes a 28-year-old elite professional football player monitored over a 6-week congested competition period. Data collection encompassed heart rate variability (HRV; RMSSD), resting heart rate (RHR), sleep parameters, neuromuscular performance (CMJ), serial biochemical markers, and genetic profiling via high-density SNP array. All data were analyzed within a within-subject longitudinal framework. Results Progressive autonomic suppression was observed (RMSSD: 62 → 38 ms, − 39%; RHR: 56 → 65 bpm). Sleep duration fell below 6 hours pre-competition and CMJ declined by ~ 20%. Biochemical findings indicated substantial physiological stress: CK reached 710 U/L, CRP increased from 0.3 to 2.0 mg/L, testosterone fell from 663 to 322 ng/dL (− 51.4%), cortisol rose from 13 to 25 µg/dL (+ 92.3%), and the testosterone-to-cortisol ratio decreased by ~ 74.7%. Following a 3–4 week individualized intervention, partial recovery was observed across all domains. Conclusion This case illustrates a multifactorial model of impaired recovery in elite sport, in which autonomic imbalance, sleep disruption, accumulated load, and genetic susceptibility interact dynamically. Integrated monitoring combining physiological, behavioral, and genomic data may enhance individualized load management in high-performance environments. Sports Medicine and Kinesiology heart rate variability autonomic recovery elite athletes training load sleep sports genomics genetic susceptibility impaired recovery 1. Introduction Interindividual variability in response to training load constitutes a central challenge in elite sport. Despite standardized training protocols, athletes exhibit markedly heterogeneous physiological adaptations, particularly regarding recovery capacity, fatigue accumulation, and injury susceptibility. Understanding the mechanisms underlying this variability is essential for implementing effective individualized load management strategies. Traditional biomarkers—including creatine kinase (CK), cortisol, and testosterone—provide limited predictive value when interpreted in isolation. Daily HRV assessment via RMSSD has gained traction as a field-applicable index of cardiac autonomic modulation, with its value enhanced when interpreted alongside resting heart rate (RHR)—the two variables together capturing the reciprocal vagal-sympathetic dynamic more robustly than either alone [ 2 , 3 ]. Despite these advances, the integration of genetic background with real-time physiological monitoring and training load data remains poorly explored in applied sports science. Polymorphisms in genes such as CLOCK and PER3 have been associated with circadian regulation and sleep phenotype; AMPD1 variants may influence energy metabolism during high-intensity efforts; and collagen-encoding genes (COL5A1, COL1A1) and inflammatory modulators (IL6, TNF, MMP3) have been linked to musculoskeletal injury susceptibility [ 14 – 17 ]. Genetic variants should not be interpreted as deterministic predictors. Rather, they function as a background susceptibility layer—modulating physiological responses to environmental stress without determining outcomes. Their clinical relevance emerges when integrated with longitudinal physiological data, not in isolation [ 15 , 22 ]. This report presents a professional elite football player who exhibited progressive impaired recovery during a congested competition period, characterized through an integrative framework combining HRV–RHR monitoring, sleep analysis, CMJ performance, serial biochemical profiling, and genetic susceptibility profiling. 2. Methods Data were collected using wearable monitoring technology, standardized neuromuscular testing, and serial biochemical assessment within a longitudinal within-subject framework over a six-week period. 2.1. Heart Rate Variability and Resting Heart Rate Cardiac autonomic status was assessed each morning via a validated short-duration recording protocol using a chest-strap sensor (Polar H10; Polar Electro Oy, Finland) in the supine position, initiated after a brief stabilization interval. Recordings were processed in Kubios HRV software with low-threshold artifact filtering and manual quality review. RMSSD served as the primary HRV index. RHR was recorded simultaneously; the combined daily RMSSD–RHR trajectory was used as the primary index of autonomic status throughout the monitoring period. 2.2. Neuromuscular Performance (CMJ) Daily neuromuscular readiness was evaluated using a bilateral countermovement jump (CMJ) protocol. Each session comprised three maximal efforts with hands placed on the iliac crests, preceded by a standardized activation sequence, with 45-second passive recovery intervals between jumps. The highest recorded value per session was retained for longitudinal analysis. Mandatory assessments were scheduled on MD-2 and MD-1 relative to each competitive fixture. 2.3. Sleep Monitoring Nocturnal sleep data were obtained continuously using a photoplethysmography-based ring device (Oura Ring; Oura Health Oy, Finland). Nightly outputs included total sleep time, sleep onset latency, wake-after-sleep-onset, and nocturnal heart rate. Data were reviewed in the context of travel schedules and competition timing. 2.4. Biochemical Assessment Fasted morning venous blood draws were performed one to two times per week. The panel included serum CK, high-sensitivity CRP, total testosterone, morning cortisol, and additional metabolic indicators. The testosterone-to-cortisol (T/C) ratio was computed from absolute values as a composite index of anabolic-catabolic balance. All values were tracked longitudinally against the athlete's own pre-season baseline. 2.5. Genetic Analysis Genetic profiling was performed using a high-density SNP array (VersaGene Full Array; DASA Laboratório, Brazil). Variants were selected a priori based on published associations in the sports genomics literature: CLOCK rs1801260 (C/T) — circadian regulation PER3 VNTR (4/5) — sleep phenotype and circadian preference AMPD1 rs17602729 (C/T) — purine nucleotide metabolism COL5A1 rs12722 (T/T) — type V collagen structure COL1A1 rs1800012 (G/T) — type I collagen structure IL6 rs1800795 (− 174 G/C) — interleukin-6 signaling TNF rs1800629 (− 308 G/A) — TNF-α inflammatory signaling MMP3 rs3025058 (5A/6A) — matrix metalloproteinase-3 and ECM remodeling Genetic data were incorporated as a contextual susceptibility layer and were not used in isolation for clinical or training decisions. 2.6. Data Integration All data were integrated within a within-subject longitudinal framework. Individual baseline values served as the primary comparator. Temporal variation, competition schedule, and multi-domain response to intervention were considered conjointly. Genetic findings were contextualized against the physiological phenotype rather than evaluated as independent predictors. 3. Case Presentation A 28-year-old male professional football player (midfielder, Brazilian Campeonato Brasileiro Série A) with 15 years of structured competitive training history was monitored over a six-week period coinciding with a congested competition schedule (two matches per week), including frequent interurban and interstate travel. The athlete reported persistent fatigue unrelieved by standard rest, subjective reduction in high-intensity performance capacity, delayed post-match recovery, and sleep disturbances particularly in the 24–48 hours preceding competition. His clinical history was notable for recurrent posterior chain injuries: proximal hamstring strains (2023 and 2026), adductor injury (2024), and soleus involvement. No acute illness, infection, or medication changes were reported during the monitoring period. 4. Results Table 1 presents the longitudinal changes across all monitored domains. Table 1 Longitudinal multi-domain monitoring data before and after intervention. Variable Baseline Nadir (pre-intervention) Post-intervention Δ (%) HRV (RMSSD, ms) 62 38 44 + 15.8% Resting HR (bpm) 56 65 62 −4.6% Sleep duration (h) ~ 7–8 < 6 ~ 7–7.5 + 15–25% Sleep latency Normal Increased Reduced — CMJ height (%) 100 ~ 80 ~ 88–92 + 8–12% Creatine kinase (U/L) — 710 Decreased — Cortisol (µg/dL) 13 25 Partial normalization + 92.3% Testosterone (ng/dL) 663 322 Partial normalization −51.4% T/C ratio 51.0 12.9 — −74.7% CRP (mg/L) 0.3 2.0 0.7 — HRV = heart rate variability; RMSSD = root mean square of successive differences; RHR = resting heart rate; CMJ = countermovement jump; CK = creatine kinase; CRP = C-reactive protein; T/C = testosterone-to-cortisol ratio. 4.1. Autonomic Function RMSSD decreased from 62 ms at baseline to 38 ms (− 39%), with partial recovery to 44 ms post-intervention (+ 15.8%). Concomitantly, RHR increased from 56 to 65 bpm at nadir, with partial reduction to 62 bpm following intervention. The reciprocal RMSSD–RHR trajectory is consistent with accumulated physiological stress and incomplete autonomic recovery. 4.2. Sleep Total sleep time fell below 6 hours on multiple pre-match nights, with prolonged sleep latency and elevated nocturnal heart rate. Following sleep optimization, total sleep time recovered to approximately 7–7.5 hours with improved efficiency and reduced latency. 4.3. Neuromuscular Performance CMJ performance declined progressively to approximately 80% of baseline (~ 20% decrement). Post-intervention values recovered to 88–92% of baseline (+ 8–12% relative to nadir), indicating partial but incomplete neuromuscular restoration. 4.4. Biochemical and Endocrine Profile CK reached 710 U/L and CRP increased from 0.3 to 2.0 mg/L, followed by reduction to 0.7 mg/L post-intervention. Testosterone decreased from 663 to 322 ng/dL (− 51.4%) while cortisol increased from 13 to 25 µg/dL (+ 92.3%), yielding a T/C ratio decline from 51.0 to 12.9 (− 74.7%), consistent with severe catabolic imbalance. 4.5. Genetic Profile Genotyping identified variants across multiple biological axes: CLOCK rs1801260 (C/T) and PER3 VNTR (4/5) in the circadian axis; AMPD1 rs17602729 (C/T) in the metabolic axis; COL5A1 rs12722 (T/T), COL1A1 rs1800012 (G/T), and MMP3 rs3025058 (5A/6A) in the connective tissue axis; and IL6 rs1800795 and TNF rs1800629 in the inflammatory axis. 5. Intervention A 3–4 week individualized, multidisciplinary intervention was implemented. 5.1. Load Management Global external training load was reduced by approximately 30–40%, with specific reductions in high-speed running (> 21 km/h), sprint distances (> 25 km/h), and high-intensity accelerations/decelerations, guided by GPS metrics and daily HRV–RHR trends. 5.2. Training Modification High metabolic load sessions were replaced with lower-density technical-tactical activities. Periodization was adjusted to ensure adequate inter-stimulus recovery within the congested match schedule. 5.3. Eccentric Load Management High-intensity eccentric loading was suspended for 7–10 days, followed by graduated reintroduction with individualized progression criteria based on HRV, RHR, and CMJ response. 5.4. Sleep Optimization A structured sleep hygiene protocol was implemented: caffeine restriction after 14:00 h; consistent sleep and wake timing; blue-light blocking in the evening; and travel-day napping protocols. Melatonin (1 mg) was administered 60–90 minutes before sleep as a chronobiotic adjunct to support circadian alignment. 6. Discussion This case provides a longitudinal, integrative characterization of impaired recovery in an elite football player under congested competition. The central contribution is methodological: individualized multimodal integrated monitoring—rather than any single biomarker—provides the most comprehensive assessment of athlete physiological status and guides effective intervention. 6.1. Autonomic Imbalance: HRV and RHR as Complementary Markers The reciprocal RMSSD–RHR trajectory constitutes a robust autonomic signal. The combined HRV–RHR longitudinal trend is more informative than either variable in isolation and is increasingly recognized as the preferred autonomic index in applied sports physiology monitoring [ 3 , 21 ]. The persistence of deviation post-intervention indicates that full autonomic recovery was not achieved, underscoring the severity of accumulated physiological load. 6.2. Sleep Disruption as a Central Mediator Pre-competitive sleep disruption—recurring across multiple match nights—likely functioned as both a consequence and an amplifier of autonomic dysregulation. Elevated nocturnal heart rate, prolonged sleep latency, and reduced total sleep time suggest an anticipatory sympathetic response potentially amplified by travel-induced circadian misalignment. This pattern likely contributed to the failure of overnight recovery to offset accumulated daily physiological strain [ 7 , 8 ]. 6.3. Neuromuscular Decline The ~ 20% CMJ decline is clinically meaningful, particularly given the athlete's recurrent posterior chain injury history. The partial post-intervention recovery (88–92% of baseline) suggests that neuromuscular readiness had not been fully restored—a relevant consideration for return-to-full-training decisions [ 9 , 10 ]. 6.4. Endocrine and Inflammatory Profile A testosterone reduction of 51.4%, cortisol elevation of 92.3%, and T/C ratio decline of 74.7% constitute objective evidence of a severe catabolic shift [ 13 ]. The simultaneous CRP elevation (0.3 → 2.0 mg/L) represents a transient low-grade inflammatory response attributable to accumulated stress rather than immune pathology. Partial normalization of all markers post-intervention is consistent with the HRV, RHR, and CMJ trajectories, reinforcing the coherence of the integrated physiological model. 6.5. Genetic Susceptibility: Contextual Mechanistic Role The genetic data provide biological plausibility for the observed phenotype, not causal explanation. The center of this work is individualized integrated physiological monitoring; genetics contextualizes, helps explain susceptibility, and provides mechanistic plausibility. This is the epistemologically mature role of genetics in applied sports science today [ 15 , 22 ]. CLOCK and PER3 variants represent the strongest genetic axis given the athlete's documented sleep phenotype. AMPD1 variants provide a plausible metabolic substrate for elevated fatigue and CK under repeated high-intensity efforts. COL5A1, COL1A1, and MMP3 variants are contextually consistent with the recurrent posterior chain injury history. IL6 and TNF variants provide plausibility for the sustained CRP elevation and prolonged recovery window. 6.6. Limitations The single-case design precludes causal inference and limits generalizability. Confounders including nutritional status, psychological stress, and travel burden were not systematically quantified. Wearable devices carry inherent measurement variability. Post-intervention absolute CK values were not fully quantified. Genetic findings remain exploratory and non-deterministic. 7. Conclusion This case demonstrates that impaired recovery in elite sport emerges from the dynamic interaction of training load, sleep disruption, autonomic imbalance, endocrine stress, and genetic susceptibility. No single biomarker provides adequate sensitivity in isolation; integrated multimodal monitoring within a longitudinal within-subject framework is required. The quantified multi-domain data—RMSSD declining 39%, RHR increasing 16%, T/C ratio decreasing 74.7%, CRP rising 6.7-fold, CMJ dropping 20%—converge to describe a coherent and clinically actionable physiological state. Genetic profiling contributed contextual mechanistic plausibility consistent with the observed phenotype, without assuming deterministic or causal roles. This approach represents a translational model for precision load management and injury risk reduction in high-performance environments. Declarations Ethics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the athlete. Consent for publication: The athlete provided written consent for anonymized publication of all data. Availability of data and materials: Available from the corresponding author upon reasonable request. Competing interests: The authors declare no competing interests. Funding: No external funding was received. Authors' contributions: RSK: conceptualization, data collection, analysis, interpretation, and manuscript drafting. RenSK: biochemical data collection and analysis, manuscript revision. RESK: genetic analysis, data interpretation, and manuscript revision. All authors approved the final manuscript. References Task Force of the European Society of Cardiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93(5):1043–1065 Plews DJ, Laursen PB, Stanley J, Kilding AE, Buchheit M (2013) Training adaptation and heart rate variability in elite endurance athletes: opening the door to effective monitoring. Sports Med 43(9):773–781 Buchheit M (2014) Monitoring training status with HRV: where do we stand and what do we need? Front Physiol 5:73 Halson SL (2014) Monitoring training load to understand fatigue in athletes. Sports Med 44(Suppl 2):S139–S147 Meeusen R, Duclos M, Foster C et al (2013) Prevention, diagnosis, and treatment of the overtraining syndrome. Eur J Sport Sci 13(1):1–24 Kellmann M, Bertollo M, Bosquet L et al (2018) Recovery and performance in sport: consensus statement. Int J Sports Physiol Perform 13(2):240–245 Fullagar HHK, Skorski S, Duffield R, Hammes D, Coutts AJ, Meyer T (2015) Sleep and athletic performance: the effects of sleep loss on exercise performance, recovery, and injury. Sports Med 45(2):161–186 Watson AM (2017) Sleep and athletic performance. Curr Sports Med Rep 16(6):413–418 Gathercole RJ, Sporer BC, Stellingwerff T, Sleivert GG (2015) Comparison of the capacity of different jump and sprint field tests to detect meaningful changes in neuromuscular status. J Strength Cond Res 29(5):1275–1283 McLean BD, Coutts AJ, Kelly V, McGuigan MR, Cormack SJ (2010) Neuromuscular, endocrine, and perceptual fatigue responses during different length between-match microcycles in professional rugby league players. Int J Sports Physiol Perform 5(3):367–383 Brancaccio P, Maffulli N, Limongelli FM (2007) Creatine kinase monitoring in sport medicine. Br Med Bull 81–82:209–230 Banfi G, Colombini A, Lombardi G, Lubkowska A (2012) Metabolic markers in sports medicine. Clin Chem Lab Med 50(4):635–644 Hackney AC (2016) Testosterone and cortisol interrelationships and sport/exercise. Endocrinol Metab Clin North Am 45(1):1–17 Ahmetov II, Fedotovskaya ON (2015) Current progress in sports genomics. Br Med Bull 114(1):35–48 Pickering C, Kiely J (2017) ACTN3: more than just a gene for speed. Sports Med 47(6):1039–1053 Heffernan SM, Kilduff LP, Erskine RM et al (2017) Genomics in elite sport: what little we know and necessary advances. Sports Med 47(6):1009–1021 Archer SN, Robilliard DL, Skene DJ et al (2003) A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26(4):413–415 Hu Y, Fu Z, Torres M et al (2026) The relationship between training load and injury risk in taekwondo: a systematic review. BMC Sports Sci Med Rehabil 18:92 Miguel M, Oliveira R, Loureiro N, García-Rubio J, Ibáñez SJ (2021) Load measures in training/match monitoring in soccer: a systematic review. Int J Environ Res Public Health 18(5):2721 Esco MR, Fields AD, Mohammadnabi MA, Kliszczewicz BM (2026) Monitoring training adaptation and recovery status in athletes using heart rate variability via mobile devices: a narrative review. Sens (Basel) 26(1):3 Semenova EA, Hall ECR, Ahmetov II (2023) Genes and athletic performance: the 2023 update. Genes (Basel) 14(6):1235 Pickering C, Kiely J (2018) Are the current guidelines on caffeine use in sport optimal for everyone? Inter-individual variation in caffeine ergogenicity, and a move towards personalised sports nutrition. Sports Med 48(1):7–16 Additional Declarations The authors declare no competing interests. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-9684599","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":639203375,"identity":"8d1aae0a-53d4-43f9-b434-e77410bbfc16","order_by":0,"name":"Rafael Silvestre Knack","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABCUlEQVRIiWNgGAWjYFACxgcMDAUMBkAWM8MHBgmw2AEwwgmYgaoNIFoYZ4C0sJGihZkHJMAGswgHMG8/zPjhgwGDsTn74cfGNhUWefLzmw8eLmC4k49Li8yZZGbJGQYMZpY9acbJOWckig2OsSUcnsHwzLIBhxYJhvwD0jwGDDYGB3KYD+e2SSRuYOMxOMzDcNgAly0S/I+Zf/8BaTn/hvmw5T+JxPlt/B/wa5FIZpMGet7M4EYOczJjg0RiwzGgevxaHrNZ9hhIGBvceGZs2HMM6LBjaUCHGTzD47Bk5hs/KmwMN5xPfizxo6YucX7z4cefeSru4NQCDwU0QEjDKBgFo2AUjAK8AAC6JlGrW/gljwAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0001-8549-8618","institution":"Hospital Israelita Albert Einstein","correspondingAuthor":true,"prefix":"","firstName":"Rafael","middleName":"Silvestre","lastName":"Knack","suffix":""},{"id":639203376,"identity":"82d9c5b9-5663-4dea-a7ea-23d9248c3dc7","order_by":1,"name":"Renata Silvestre Knack","email":"","orcid":"","institution":"FAEPE – Fundação de Apoio ao Ensino, Pesquisa e Extensão (FAMERP","correspondingAuthor":false,"prefix":"","firstName":"Renata","middleName":"Silvestre","lastName":"Knack","suffix":""},{"id":639203377,"identity":"d78b4caa-fc77-44cf-bf90-667744ce8497","order_by":2,"name":"Ricardo Egídio Silvestre Knack","email":"","orcid":"","institution":"Centro Universitário Claretiano","correspondingAuthor":false,"prefix":"","firstName":"Ricardo","middleName":"Egídio Silvestre","lastName":"Knack","suffix":""}],"badges":[],"createdAt":"2026-05-11 23:35:30","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-9684599/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-9684599/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":109143130,"identity":"04234d97-3f6d-4fd7-9d13-c3480f096b9b","added_by":"auto","created_at":"2026-05-13 03:10:39","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":202461,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-9684599/v1/266b68d4-58d3-4a0a-ad53-ab0b1d2c09cb.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"Impaired Recovery Duri\nng Congested Competition in an Elite Football Player: A Longitudinal Integrative Case Report","fulltext":[{"header":"1. Introduction","content":"\u003cp\u003eInterindividual variability in response to training load constitutes a central challenge in elite sport. Despite standardized training protocols, athletes exhibit markedly heterogeneous physiological adaptations, particularly regarding recovery capacity, fatigue accumulation, and injury susceptibility. Understanding the mechanisms underlying this variability is essential for implementing effective individualized load management strategies.\u003c/p\u003e \u003cp\u003eTraditional biomarkers\u0026mdash;including creatine kinase (CK), cortisol, and testosterone\u0026mdash;provide limited predictive value when interpreted in isolation. Daily HRV assessment via RMSSD has gained traction as a field-applicable index of cardiac autonomic modulation, with its value enhanced when interpreted alongside resting heart rate (RHR)\u0026mdash;the two variables together capturing the reciprocal vagal-sympathetic dynamic more robustly than either alone [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eDespite these advances, the integration of genetic background with real-time physiological monitoring and training load data remains poorly explored in applied sports science. Polymorphisms in genes such as CLOCK and PER3 have been associated with circadian regulation and sleep phenotype; AMPD1 variants may influence energy metabolism during high-intensity efforts; and collagen-encoding genes (COL5A1, COL1A1) and inflammatory modulators (IL6, TNF, MMP3) have been linked to musculoskeletal injury susceptibility [\u003cspan additionalcitationids=\"CR15 CR16\" citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eGenetic variants should not be interpreted as deterministic predictors. Rather, they function as a background susceptibility layer\u0026mdash;modulating physiological responses to environmental stress without determining outcomes. Their clinical relevance emerges when integrated with longitudinal physiological data, not in isolation [\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eThis report presents a professional elite football player who exhibited progressive impaired recovery during a congested competition period, characterized through an integrative framework combining HRV\u0026ndash;RHR monitoring, sleep analysis, CMJ performance, serial biochemical profiling, and genetic susceptibility profiling.\u003c/p\u003e"},{"header":"2. Methods","content":"\u003cp\u003eData were collected using wearable monitoring technology, standardized neuromuscular testing, and serial biochemical assessment within a longitudinal within-subject framework over a six-week period.\u003c/p\u003e \u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003e2.1. Heart Rate Variability and Resting Heart Rate\u003c/h2\u003e \u003cp\u003eCardiac autonomic status was assessed each morning via a validated short-duration recording protocol using a chest-strap sensor (Polar H10; Polar Electro Oy, Finland) in the supine position, initiated after a brief stabilization interval. Recordings were processed in Kubios HRV software with low-threshold artifact filtering and manual quality review. RMSSD served as the primary HRV index. RHR was recorded simultaneously; the combined daily RMSSD\u0026ndash;RHR trajectory was used as the primary index of autonomic status throughout the monitoring period.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003e2.2. Neuromuscular Performance (CMJ)\u003c/h2\u003e \u003cp\u003eDaily neuromuscular readiness was evaluated using a bilateral countermovement jump (CMJ) protocol. Each session comprised three maximal efforts with hands placed on the iliac crests, preceded by a standardized activation sequence, with 45-second passive recovery intervals between jumps. The highest recorded value per session was retained for longitudinal analysis. Mandatory assessments were scheduled on MD-2 and MD-1 relative to each competitive fixture.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec5\" class=\"Section2\"\u003e \u003ch2\u003e2.3. Sleep Monitoring\u003c/h2\u003e \u003cp\u003eNocturnal sleep data were obtained continuously using a photoplethysmography-based ring device (Oura Ring; Oura Health Oy, Finland). Nightly outputs included total sleep time, sleep onset latency, wake-after-sleep-onset, and nocturnal heart rate. Data were reviewed in the context of travel schedules and competition timing.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003e2.4. Biochemical Assessment\u003c/h2\u003e \u003cp\u003eFasted morning venous blood draws were performed one to two times per week. The panel included serum CK, high-sensitivity CRP, total testosterone, morning cortisol, and additional metabolic indicators. The testosterone-to-cortisol (T/C) ratio was computed from absolute values as a composite index of anabolic-catabolic balance. All values were tracked longitudinally against the athlete's own pre-season baseline.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec7\" class=\"Section2\"\u003e \u003ch2\u003e2.5. Genetic Analysis\u003c/h2\u003e \u003cp\u003eGenetic profiling was performed using a high-density SNP array (VersaGene Full Array; DASA Laborat\u0026oacute;rio, Brazil). Variants were selected a priori based on published associations in the sports genomics literature:\u003c/p\u003e \u003cp\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eCLOCK rs1801260 (C/T) \u0026mdash; circadian regulation\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003ePER3 VNTR (4/5) \u0026mdash; sleep phenotype and circadian preference\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003eAMPD1 rs17602729 (C/T) \u0026mdash; purine nucleotide metabolism\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003eCOL5A1 rs12722 (T/T) \u0026mdash; type V collagen structure\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003eCOL1A1 rs1800012 (G/T) \u0026mdash; type I collagen structure\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003eIL6 rs1800795 (\u0026minus;\u0026thinsp;174 G/C) \u0026mdash; interleukin-6 signaling\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003eTNF rs1800629 (\u0026minus;\u0026thinsp;308 G/A) \u0026mdash; TNF-α inflammatory signaling\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003eMMP3 rs3025058 (5A/6A) \u0026mdash; matrix metalloproteinase-3 and ECM remodeling\u003c/p\u003e \u003c/li\u003e \u003c/ul\u003e \u003c/p\u003e \u003cp\u003eGenetic data were incorporated as a contextual susceptibility layer and were not used in isolation for clinical or training decisions.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003e2.6. Data Integration\u003c/h2\u003e \u003cp\u003eAll data were integrated within a within-subject longitudinal framework. Individual baseline values served as the primary comparator. Temporal variation, competition schedule, and multi-domain response to intervention were considered conjointly. Genetic findings were contextualized against the physiological phenotype rather than evaluated as independent predictors.\u003c/p\u003e \u003c/div\u003e"},{"header":"3. Case Presentation","content":"\u003cp\u003eA 28-year-old male professional football player (midfielder, Brazilian Campeonato Brasileiro S\u0026eacute;rie A) with 15 years of structured competitive training history was monitored over a six-week period coinciding with a congested competition schedule (two matches per week), including frequent interurban and interstate travel.\u003c/p\u003e \u003cp\u003eThe athlete reported persistent fatigue unrelieved by standard rest, subjective reduction in high-intensity performance capacity, delayed post-match recovery, and sleep disturbances particularly in the 24\u0026ndash;48 hours preceding competition. His clinical history was notable for recurrent posterior chain injuries: proximal hamstring strains (2023 and 2026), adductor injury (2024), and soleus involvement. No acute illness, infection, or medication changes were reported during the monitoring period.\u003c/p\u003e"},{"header":"4. Results","content":"\u003cp\u003eTable\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e presents the longitudinal changes across all monitored domains.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eLongitudinal multi-domain monitoring data before and after intervention.\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003e Variable\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eBaseline\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eNadir (pre-intervention)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003ePost-intervention\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eΔ (%)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eHRV (RMSSD, ms)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e62\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e38\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e44\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e+\u0026thinsp;15.8%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eResting HR (bpm)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e56\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e65\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e62\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026minus;4.6%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eSleep duration (h)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e~\u0026thinsp;7\u0026ndash;8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026lt;\u0026thinsp;6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e~\u0026thinsp;7\u0026ndash;7.5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e+\u0026thinsp;15\u0026ndash;25%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eSleep latency\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eNormal\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eIncreased\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003eReduced\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026mdash;\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCMJ height (%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e100\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e~\u0026thinsp;80\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e~\u0026thinsp;88\u0026ndash;92\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e+\u0026thinsp;8\u0026ndash;12%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCreatine kinase (U/L)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u0026mdash;\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e710\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003eDecreased\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026mdash;\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCortisol (\u0026micro;g/dL)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e13\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e25\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003ePartial normalization\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e+\u0026thinsp;92.3%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eTestosterone (ng/dL)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e663\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e322\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003ePartial normalization\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026minus;51.4%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eT/C ratio\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e51.0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e12.9\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e\u0026mdash;\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026minus;74.7%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCRP (mg/L)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e0.3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2.0\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0.7\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u0026mdash;\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cem\u003eHRV\u0026thinsp;=\u0026thinsp;heart rate variability; RMSSD\u0026thinsp;=\u0026thinsp;root mean square of successive differences; RHR\u0026thinsp;=\u0026thinsp;resting heart rate; CMJ\u0026thinsp;=\u0026thinsp;countermovement jump; CK\u0026thinsp;=\u0026thinsp;creatine kinase; CRP\u0026thinsp;=\u0026thinsp;C-reactive protein; T/C\u0026thinsp;=\u0026thinsp;testosterone-to-cortisol ratio.\u003c/em\u003e \u003c/p\u003e \u003cdiv id=\"Sec11\" class=\"Section2\"\u003e \u003ch2\u003e4.1. Autonomic Function\u003c/h2\u003e \u003cp\u003eRMSSD decreased from 62 ms at baseline to 38 ms (\u0026minus;\u0026thinsp;39%), with partial recovery to 44 ms post-intervention (+\u0026thinsp;15.8%). Concomitantly, RHR increased from 56 to 65 bpm at nadir, with partial reduction to 62 bpm following intervention. The reciprocal RMSSD\u0026ndash;RHR trajectory is consistent with accumulated physiological stress and incomplete autonomic recovery.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec12\" class=\"Section2\"\u003e \u003ch2\u003e4.2. Sleep\u003c/h2\u003e \u003cp\u003eTotal sleep time fell below 6 hours on multiple pre-match nights, with prolonged sleep latency and elevated nocturnal heart rate. Following sleep optimization, total sleep time recovered to approximately 7\u0026ndash;7.5 hours with improved efficiency and reduced latency.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec13\" class=\"Section2\"\u003e \u003ch2\u003e4.3. Neuromuscular Performance\u003c/h2\u003e \u003cp\u003eCMJ performance declined progressively to approximately 80% of baseline (~\u0026thinsp;20% decrement). Post-intervention values recovered to 88\u0026ndash;92% of baseline (+\u0026thinsp;8\u0026ndash;12% relative to nadir), indicating partial but incomplete neuromuscular restoration.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec14\" class=\"Section2\"\u003e \u003ch2\u003e4.4. Biochemical and Endocrine Profile\u003c/h2\u003e \u003cp\u003eCK reached 710 U/L and CRP increased from 0.3 to 2.0 mg/L, followed by reduction to 0.7 mg/L post-intervention. Testosterone decreased from 663 to 322 ng/dL (\u0026minus;\u0026thinsp;51.4%) while cortisol increased from 13 to 25 \u0026micro;g/dL (+\u0026thinsp;92.3%), yielding a T/C ratio decline from 51.0 to 12.9 (\u0026minus;\u0026thinsp;74.7%), consistent with severe catabolic imbalance.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec15\" class=\"Section2\"\u003e \u003ch2\u003e4.5. Genetic Profile\u003c/h2\u003e \u003cp\u003eGenotyping identified variants across multiple biological axes: CLOCK rs1801260 (C/T) and PER3 VNTR (4/5) in the circadian axis; AMPD1 rs17602729 (C/T) in the metabolic axis; COL5A1 rs12722 (T/T), COL1A1 rs1800012 (G/T), and MMP3 rs3025058 (5A/6A) in the connective tissue axis; and IL6 rs1800795 and TNF rs1800629 in the inflammatory axis.\u003c/p\u003e \u003c/div\u003e"},{"header":"5. Intervention","content":"\u003cp\u003eA 3\u0026ndash;4 week individualized, multidisciplinary intervention was implemented.\u003c/p\u003e \u003cdiv id=\"Sec17\" class=\"Section2\"\u003e \u003ch2\u003e5.1. Load Management\u003c/h2\u003e \u003cp\u003eGlobal external training load was reduced by approximately 30\u0026ndash;40%, with specific reductions in high-speed running (\u0026gt;\u0026thinsp;21 km/h), sprint distances (\u0026gt;\u0026thinsp;25 km/h), and high-intensity accelerations/decelerations, guided by GPS metrics and daily HRV\u0026ndash;RHR trends.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec18\" class=\"Section2\"\u003e \u003ch2\u003e5.2. Training Modification\u003c/h2\u003e \u003cp\u003eHigh metabolic load sessions were replaced with lower-density technical-tactical activities. Periodization was adjusted to ensure adequate inter-stimulus recovery within the congested match schedule.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec19\" class=\"Section2\"\u003e \u003ch2\u003e5.3. Eccentric Load Management\u003c/h2\u003e \u003cp\u003eHigh-intensity eccentric loading was suspended for 7\u0026ndash;10 days, followed by graduated reintroduction with individualized progression criteria based on HRV, RHR, and CMJ response.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec20\" class=\"Section2\"\u003e \u003ch2\u003e5.4. Sleep Optimization\u003c/h2\u003e \u003cp\u003eA structured sleep hygiene protocol was implemented: caffeine restriction after 14:00 h; consistent sleep and wake timing; blue-light blocking in the evening; and travel-day napping protocols. Melatonin (1 mg) was administered 60\u0026ndash;90 minutes before sleep as a chronobiotic adjunct to support circadian alignment.\u003c/p\u003e \u003c/div\u003e"},{"header":"6. Discussion","content":"\u003cp\u003eThis case provides a longitudinal, integrative characterization of impaired recovery in an elite football player under congested competition. The central contribution is methodological: individualized multimodal integrated monitoring\u0026mdash;rather than any single biomarker\u0026mdash;provides the most comprehensive assessment of athlete physiological status and guides effective intervention.\u003c/p\u003e \u003cdiv id=\"Sec22\" class=\"Section2\"\u003e \u003ch2\u003e6.1. Autonomic Imbalance: HRV and RHR as Complementary Markers\u003c/h2\u003e \u003cp\u003eThe reciprocal RMSSD\u0026ndash;RHR trajectory constitutes a robust autonomic signal. The combined HRV\u0026ndash;RHR longitudinal trend is more informative than either variable in isolation and is increasingly recognized as the preferred autonomic index in applied sports physiology monitoring [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e, \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. The persistence of deviation post-intervention indicates that full autonomic recovery was not achieved, underscoring the severity of accumulated physiological load.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec23\" class=\"Section2\"\u003e \u003ch2\u003e6.2. Sleep Disruption as a Central Mediator\u003c/h2\u003e \u003cp\u003ePre-competitive sleep disruption\u0026mdash;recurring across multiple match nights\u0026mdash;likely functioned as both a consequence and an amplifier of autonomic dysregulation. Elevated nocturnal heart rate, prolonged sleep latency, and reduced total sleep time suggest an anticipatory sympathetic response potentially amplified by travel-induced circadian misalignment. This pattern likely contributed to the failure of overnight recovery to offset accumulated daily physiological strain [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e, \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e].\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec24\" class=\"Section2\"\u003e \u003ch2\u003e6.3. Neuromuscular Decline\u003c/h2\u003e \u003cp\u003eThe ~\u0026thinsp;20% CMJ decline is clinically meaningful, particularly given the athlete's recurrent posterior chain injury history. The partial post-intervention recovery (88\u0026ndash;92% of baseline) suggests that neuromuscular readiness had not been fully restored\u0026mdash;a relevant consideration for return-to-full-training decisions [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e, \u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e].\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec25\" class=\"Section2\"\u003e \u003ch2\u003e6.4. Endocrine and Inflammatory Profile\u003c/h2\u003e \u003cp\u003eA testosterone reduction of 51.4%, cortisol elevation of 92.3%, and T/C ratio decline of 74.7% constitute objective evidence of a severe catabolic shift [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. The simultaneous CRP elevation (0.3 \u0026rarr; 2.0 mg/L) represents a transient low-grade inflammatory response attributable to accumulated stress rather than immune pathology. Partial normalization of all markers post-intervention is consistent with the HRV, RHR, and CMJ trajectories, reinforcing the coherence of the integrated physiological model.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec26\" class=\"Section2\"\u003e \u003ch2\u003e6.5. Genetic Susceptibility: Contextual Mechanistic Role\u003c/h2\u003e \u003cp\u003eThe genetic data provide biological plausibility for the observed phenotype, not causal explanation. The center of this work is individualized integrated physiological monitoring; genetics contextualizes, helps explain susceptibility, and provides mechanistic plausibility. This is the epistemologically mature role of genetics in applied sports science today [\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eCLOCK and PER3 variants represent the strongest genetic axis given the athlete's documented sleep phenotype. AMPD1 variants provide a plausible metabolic substrate for elevated fatigue and CK under repeated high-intensity efforts. COL5A1, COL1A1, and MMP3 variants are contextually consistent with the recurrent posterior chain injury history. IL6 and TNF variants provide plausibility for the sustained CRP elevation and prolonged recovery window.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec27\" class=\"Section2\"\u003e \u003ch2\u003e6.6. Limitations\u003c/h2\u003e \u003cp\u003eThe single-case design precludes causal inference and limits generalizability. Confounders including nutritional status, psychological stress, and travel burden were not systematically quantified. Wearable devices carry inherent measurement variability. Post-intervention absolute CK values were not fully quantified. Genetic findings remain exploratory and non-deterministic.\u003c/p\u003e \u003c/div\u003e"},{"header":"7. Conclusion","content":"\u003cp\u003eThis case demonstrates that impaired recovery in elite sport emerges from the dynamic interaction of training load, sleep disruption, autonomic imbalance, endocrine stress, and genetic susceptibility. No single biomarker provides adequate sensitivity in isolation; integrated multimodal monitoring within a longitudinal within-subject framework is required.\u003c/p\u003e \u003cp\u003eThe quantified multi-domain data\u0026mdash;RMSSD declining 39%, RHR increasing 16%, T/C ratio decreasing 74.7%, CRP rising 6.7-fold, CMJ dropping 20%\u0026mdash;converge to describe a coherent and clinically actionable physiological state. Genetic profiling contributed contextual mechanistic plausibility consistent with the observed phenotype, without assuming deterministic or causal roles.\u003c/p\u003e \u003cp\u003eThis approach represents a translational model for precision load management and injury risk reduction in high-performance environments.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003eEthics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the athlete.\u003c/p\u003e\n\u003cp\u003eConsent for publication: The athlete provided written consent for anonymized publication of all data.\u003c/p\u003e\n\u003cp\u003eAvailability of data and materials: Available from the corresponding author upon reasonable request.\u003c/p\u003e\n\u003cp\u003eCompeting interests: The authors declare no competing interests.\u003c/p\u003e\n\u003cp\u003eFunding: No external funding was received.\u003c/p\u003e\n\u003cp\u003eAuthors\u0026apos; contributions: RSK: conceptualization, data collection, analysis, interpretation, and manuscript drafting. RenSK: biochemical data collection and analysis, manuscript revision. RESK: genetic analysis, data interpretation, and manuscript revision. All authors approved the final manuscript.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eTask Force of the European Society of Cardiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93(5):1043\u0026ndash;1065\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePlews DJ, Laursen PB, Stanley J, Kilding AE, Buchheit M (2013) Training adaptation and heart rate variability in elite endurance athletes: opening the door to effective monitoring. Sports Med 43(9):773\u0026ndash;781\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBuchheit M (2014) Monitoring training status with HRV: where do we stand and what do we need? Front Physiol 5:73\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHalson SL (2014) Monitoring training load to understand fatigue in athletes. Sports Med 44(Suppl 2):S139\u0026ndash;S147\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMeeusen R, Duclos M, Foster C et al (2013) Prevention, diagnosis, and treatment of the overtraining syndrome. Eur J Sport Sci 13(1):1\u0026ndash;24\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKellmann M, Bertollo M, Bosquet L et al (2018) Recovery and performance in sport: consensus statement. Int J Sports Physiol Perform 13(2):240\u0026ndash;245\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eFullagar HHK, Skorski S, Duffield R, Hammes D, Coutts AJ, Meyer T (2015) Sleep and athletic performance: the effects of sleep loss on exercise performance, recovery, and injury. Sports Med 45(2):161\u0026ndash;186\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWatson AM (2017) Sleep and athletic performance. Curr Sports Med Rep 16(6):413\u0026ndash;418\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGathercole RJ, Sporer BC, Stellingwerff T, Sleivert GG (2015) Comparison of the capacity of different jump and sprint field tests to detect meaningful changes in neuromuscular status. J Strength Cond Res 29(5):1275\u0026ndash;1283\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMcLean BD, Coutts AJ, Kelly V, McGuigan MR, Cormack SJ (2010) Neuromuscular, endocrine, and perceptual fatigue responses during different length between-match microcycles in professional rugby league players. Int J Sports Physiol Perform 5(3):367\u0026ndash;383\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBrancaccio P, Maffulli N, Limongelli FM (2007) Creatine kinase monitoring in sport medicine. Br Med Bull 81\u0026ndash;82:209\u0026ndash;230\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBanfi G, Colombini A, Lombardi G, Lubkowska A (2012) Metabolic markers in sports medicine. Clin Chem Lab Med 50(4):635\u0026ndash;644\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHackney AC (2016) Testosterone and cortisol interrelationships and sport/exercise. Endocrinol Metab Clin North Am 45(1):1\u0026ndash;17\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAhmetov II, Fedotovskaya ON (2015) Current progress in sports genomics. Br Med Bull 114(1):35\u0026ndash;48\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePickering C, Kiely J (2017) ACTN3: more than just a gene for speed. Sports Med 47(6):1039\u0026ndash;1053\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHeffernan SM, Kilduff LP, Erskine RM et al (2017) Genomics in elite sport: what little we know and necessary advances. Sports Med 47(6):1009\u0026ndash;1021\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eArcher SN, Robilliard DL, Skene DJ et al (2003) A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26(4):413\u0026ndash;415\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHu Y, Fu Z, Torres M et al (2026) The relationship between training load and injury risk in taekwondo: a systematic review. BMC Sports Sci Med Rehabil 18:92\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMiguel M, Oliveira R, Loureiro N, Garc\u0026iacute;a-Rubio J, Ib\u0026aacute;\u0026ntilde;ez SJ (2021) Load measures in training/match monitoring in soccer: a systematic review. Int J Environ Res Public Health 18(5):2721\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEsco MR, Fields AD, Mohammadnabi MA, Kliszczewicz BM (2026) Monitoring training adaptation and recovery status in athletes using heart rate variability via mobile devices: a narrative review. Sens (Basel) 26(1):3\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSemenova EA, Hall ECR, Ahmetov II (2023) Genes and athletic performance: the 2023 update. Genes (Basel) 14(6):1235\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePickering C, Kiely J (2018) Are the current guidelines on caffeine use in sport optimal for everyone? Inter-individual variation in caffeine ergogenicity, and a move towards personalised sports nutrition. Sports Med 48(1):7\u0026ndash;16\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"heart rate variability, autonomic recovery, elite athletes, training load, sleep, sports genomics, genetic susceptibility, impaired recovery","lastPublishedDoi":"10.21203/rs.3.rs-9684599/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-9684599/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eBackground\u003c/h2\u003e \u003cp\u003eInterindividual variability in recovery responses represents a central challenge in elite sports, particularly during congested competition periods. Traditional biomarkers provide limited predictive value when used in isolation, highlighting the need for integrative multimodal monitoring approaches.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e \u003cp\u003eThis longitudinal case report describes a 28-year-old elite professional football player monitored over a 6-week congested competition period. Data collection encompassed heart rate variability (HRV; RMSSD), resting heart rate (RHR), sleep parameters, neuromuscular performance (CMJ), serial biochemical markers, and genetic profiling via high-density SNP array. All data were analyzed within a within-subject longitudinal framework.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e \u003cp\u003eProgressive autonomic suppression was observed (RMSSD: 62 \u0026rarr; 38 ms, \u0026minus;\u0026thinsp;39%; RHR: 56 \u0026rarr; 65 bpm). Sleep duration fell below 6 hours pre-competition and CMJ declined by ~\u0026thinsp;20%. Biochemical findings indicated substantial physiological stress: CK reached 710 U/L, CRP increased from 0.3 to 2.0 mg/L, testosterone fell from 663 to 322 ng/dL (\u0026minus;\u0026thinsp;51.4%), cortisol rose from 13 to 25 \u0026micro;g/dL (+\u0026thinsp;92.3%), and the testosterone-to-cortisol ratio decreased by ~\u0026thinsp;74.7%. Following a 3\u0026ndash;4 week individualized intervention, partial recovery was observed across all domains.\u003c/p\u003e\u003ch2\u003eConclusion\u003c/h2\u003e \u003cp\u003eThis case illustrates a multifactorial model of impaired recovery in elite sport, in which autonomic imbalance, sleep disruption, accumulated load, and genetic susceptibility interact dynamically. Integrated monitoring combining physiological, behavioral, and genomic data may enhance individualized load management in high-performance environments.\u003c/p\u003e","manuscriptTitle":"Impaired Recovery Duri\nng Congested Competition in an Elite Football Player: A Longitudinal Integrative Case Report","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-05-13 03:08:06","doi":"10.21203/rs.3.rs-9684599/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"7a1e891b-a904-4853-9f73-40733ab161e0","owner":[],"postedDate":"May 13th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":68034360,"name":"Sports Medicine and Kinesiology"}],"tags":[],"updatedAt":"2026-05-13T03:08:06+00:00","versionOfRecord":[],"versionCreatedAt":"2026-05-13 03:08:06","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-9684599","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-9684599","identity":"rs-9684599","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}